- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/10 - Radicals substituted by halogen atoms or nitro radicals
Patent holdings for IPC class C07D 235/10
Total number of patents in this class: 110
10-year publication summary
|
7
|
9
|
7
|
7
|
7
|
6
|
5
|
6
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline LLC | 532 |
5 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Kumiai Chemical Industry Co., Ltd. | 312 |
4 |
| Nippon Shinyaku Co., Ltd. | 328 |
4 |
| Merial, Inc. | 216 |
3 |
| Hoffmann-La Roche Inc. | 3620 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2792 |
2 |
| Cornell University | 3386 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2637 |
2 |
| Indiana University Research and Technology Corporation | 794 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 701 |
2 |
| Nanjing Tech University | 282 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 662 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2947 |
2 |
| Vectus Biosystems Limited | 29 |
2 |
| Adamed Pharma S.A. | 151 |
2 |
| Vitae Pharmaceuticals, LLC | 39 |
2 |
| Xiamen Vivohealths Technology Co., Ltd. | 7 |
2 |
| Plex Pharmaceuticals, Inc. | 17 |
2 |
| Suzhou Mednes Pharma Tech Co., Ltd. | 4 |
2 |
| Other owners | 60 |